USPTO 2015–2025 USPTO PatentsView US Corporation

Bard Peripheral Vascular, Inc.

USPTO PatentsView assignee record - 114 granted patents across 26 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

114

Total patents granted

CPC technology areas

15.6

Avg claims per patent

+48%

5-year filing velocity

The verdict

Bard holds 114 US patents across 26 technology areas, rank #3,273 of 50,000 tracked assignees.

#3,273
of 50,000 US assignees by volume: Top 12%
by Innovation Score (51.3/100): 15.6
avg claims per patent: +48%
filing velocity, last 5 yrs

Portfolio overview

Bard Peripheral Vascular, Inc. has been granted 114 US utility patents between 2015 and 2025, placing Bard Peripheral Vascular, Inc. at rank #3,273 across all assignees tracked by PlainPatent. This portfolio spans 26 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Bard Peripheral Vascular, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Bard sits between UTI Inc. (115 patents, rank #3,269) and Equinor Energy AS (114 patents, rank #3,277) - the closest US assignees by grant volume. The composite Innovation Score of 51.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 68 grants, compared with 46 in the 2015–2019 window, a +48% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Bard Peripheral Vascular, Inc.'s 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 26 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bard Peripheral Vascular, Inc. against peers pursuing similar technology classes.

UTI

115
Abbyy Development

114
Asana

114
Baidu COM Times T…

114
Chia Tai Tianqing…

114
Creeled

114
Dreamwell

114
Equinor Energy AS

114
Bard Peripheral V… ◀

114

What this shows Bard holds 114 patents at rank #3,273, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bard

By rank, the assignees closest to #3,273 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Bard's primary technology class.

Bard's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bard Peripheral Vascular, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	7.0%
2016	9	7.9%
2017	6	5.3%
2018	9	7.9%
2019	14	12.3%
2020	11	9.6%
2021	7	6.1%
2022	8	7.0%
2023	11	9.6%
2024	17	14.9%
2025	14	12.3%

Which technologies does Bard Peripheral Vascular, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 71

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 69

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 28

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 11

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 11

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 9

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 9

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8

B29K - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR ; MOULDS, ; REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS 7

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 7

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 7

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 6

D04C - BRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE 5

B32B - LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM 4

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 3

Top 15 of 26 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#3,273

Across all tracked assignees

Innovation Score

51.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Bard Peripheral Vascular, Inc. hold?

Bard Peripheral Vascular, Inc. holds 114 US granted patents filed between 2015 and 2025, spanning 26 technology areas.

What is Bard Peripheral Vascular, Inc.'s Innovation Score?

Bard Peripheral Vascular, Inc. has an Innovation Score of 51.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bard Peripheral Vascular, Inc. focus on?

Bard Peripheral Vascular, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 71 patents. The company has filed patents in 26 CPC subclasses total.

Is Bard Peripheral Vascular, Inc.'s patent filing rate increasing or decreasing?

Bard Peripheral Vascular, Inc.'s recent filing velocity is +48% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Bard Peripheral Vascular, Inc.'s patents?

Bard Peripheral Vascular, Inc.'s patents average 15.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Bard Peripheral Vascular, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Bard's 114 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Bard ranks #3,273 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.